Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsSimply Healthcare Methotrexate Prior Auth | OpenPa…
    Ask Trek AI about this page
    CurrentSimply HealthcarePolicy N/A

    Oral Methotrexate Solution Step Therapy

    Customize your policy alerts

    Sign up for all simplyhealthcare policy alerts

    Know when simplyhealthcare releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs authorization for Jylamvo and Xatmep oral methotrexate solutions under Simply Healthcare's step therapy program. Coverage for these Step 2 products requires the patient to have tried oral methotrexate sodium as the Step 1 drug.

    Policy Summary
    PayerSimply Healthcare
    PolicyOral Methotrexate Solution Step Therapy
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateOct 1, 2026
    Next Review DateN/A
    Key ActionDocument that the patient has tried oral methotrexate sodium before requesting authorization for Jylamvo or Xatmep.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    2Step 2 products affected
    1Required Step 1 drug
    2Step therapy levels

    Jylamvo and Xatmep Coverage Criteria

    Jylamvo and Xatmep Step Therapy

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Authorization for a Step 2 drug is covered when ALL of the following criteria are met:

    ALL of the following

    • The patient has tried the Step 1 drug: oral methotrexate sodium.
    • The requested drug is ONE of the following Step 2 drugs

      • Jylamvo (methotrexate).
      • Xatmep (methotrexate).

    Required Documentation and Step Therapy Actions

    Documentation Required

    Document Step 1 Trial

    Document that the patient has tried oral methotrexate sodium before requesting authorization for Jylamvo or Xatmep.

    Step Therapy

    Step 1 Trial Required Before Step 2 Coverage

    The patient must try oral methotrexate sodium, the Step 1 drug, before authorization for a Step 2 drug is covered.

    • Step 2 drugs: Jylamvo (methotrexate) and Xatmep (methotrexate).
    Denial Risk

    Denial Risk Without Step 1 Trial

    Authorization may be denied when the patient has not tried oral methotrexate sodium. Include the prior trial in the clinical documentation before requesting coverage for Jylamvo or Xatmep.

    Initial Authorization Criteria

    Initial Authorization After Step 1 Trial

    Authorization is covered after the required Step 1 trial.

    Required prior therapy: The patient has tried oral methotrexate sodium before receiving Jylamvo or Xatmep.

    Oral methotrexate sodium is the Step 1 drug; Jylamvo and Xatmep are Step 2 drugs.

    Step Therapy Sequence

    StepDrug(s)Requirement
    Step 1Oral methotrexate sodiumTry before requesting authorization for a Step 2 drug.
    Step 2Jylamvo (methotrexate) or Xatmep (methotrexate)Authorization is covered after the Step 1 drug has been tried.
    Policy Summary
    PayerSimply Healthcare
    PolicyOral Methotrexate Solution Step Therapy
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateOct 1, 2026
    Next Review DateN/A
    Key ActionDocument that the patient has tried oral methotrexate sodium before requesting authorization for Jylamvo or Xatmep.
    SourceLink
    On This Page
    Jylamvo and Xatmep Coverage CriteriaRequired Documentation and Step Therapy ActionsInitial Authorization CriteriaStep Therapy Sequence